PMDA drug package insert
イルアミクス配合錠LD「サワイ」
PMDA Prescription drug · 沢井製薬株式会社 · package insert Dec 16, 2025
Key facts
| Brand names | イルアミクス配合錠LD「サワイ」, イルアミクス配合錠HD「サワイ」 |
|---|---|
| Nonproprietary names | イルベサルタン・アムロジピンベシル酸塩配合剤 |
| Companies | 製造販売元／沢井製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 長時間作用型ARB/持続性Ca拮抗薬配合剤 |
| Therapeutic category codes | 872149 |
| YJ codes | 2149118F1119, 2149118F2115 |
| Approval numbers | 23000AMX00320000, 23000AMX00321000 |
| Package insert edition | 第4版 |
| Package insert date | Dec 16, 2025 |
| PMDA document key | 300119_2149118F1119_1 |
| PMDA company code | 300119 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: